References
- Kabelitz D, Janssen O. Growth inhibition of Epstein-Barr virus-transformed B cells by anti-HLA-DR antibody L243: possible relationship to L243-induced down-regulation of CD23 antigen expression. Cell Immunol 1989;120:21–30.
- Altomonte M, Pucillo C, Damante G, Maio M. Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-α by the EBV-B lymphoblastoid cell line JY. J Immunol 1993;151:5115–5122.
- Gingrich RD, Dahle CE, Hoskins KF, Senneff MJ. Identification and characterization of a new surface membrane antigen found predominantly on malignant B lymphocytes. Blood 1990;75:2375–2387.
- Kostelny SA, Link BK, Tso JY, et al Humanization and characterization of the anti-HLA-DR antibody 1D10. Int J Cancer 2001;93:556–565.
- Stockmeyer B, Schiller M, Repp R, et al Enhanced killing of B lymphoma cells by granulocyte colony-stimulating factor-primed effector cells and Hu1D10 – a humanized human leucocyte antigen DR antibody. Br J Haematol 2002;118:959–967.
- Bains SK, Mone A, Yun Tso J, et al Mitochondria control of cell death induced by anti-HLA-DR antibodies. Leukemia 2003;17:1357–1365.
- Mone AP, Huang P, Pelicano H, et al Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells. Blood 2004;103:1846–1854.
- Link B, Wang H, Byrd J. Phase I study of Hu1D10 monoclonal antibody in patients with B-cell lymphoma. Proc Am Soc Clin Oncol 2001;20:284a (abstract 1135).
- Link B, Kahl B, Czuczman M. A Phase II study of Remitogen (Hu1D10), a humanized monoclonal antibody in patients with relapsed or refractory follicular, small lymphocytic, or marginal zone/MALT B-cell lymphoma. Blood 2001;98:606a (abstract 2540).
- Lin T, Stock W, Xu H. A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped up dosing schedule in patients with chronic lymphocytic leukemia (CLL) and acute leukemia. Leuk Lymphoma 2009, in press.
- Dunleavy K, White T, Grant N. Phase I study of combination rituximab with apolizumab in relapsed/ refractory B-cell lymphoma and chronic lymphocytic leukemia. J Clin Oncol 2005;25:586s (abstract 6607).
- Hasegawa S, Becker G, Nagano H, Libby P, Mitchell RN. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells. Am J Pathol 1998;153:69–79.
- Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis. Arthritis Rheum 2002;46:862–873.
- Moris G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis. Arch Intern Med 1999;159: 1185–1194.